Acute Oral Toxicity of (E)-1,2,3,4-Tetrahydro-6-Methyl-1-(2-Methyl-1- Oxo-2-Butenyl) Quinoline (CHR5) in Male and Female Rats
Abstract
The acute oral toxicity of (E)-1,2,3,4-tetrahydro-6-methyl-1-(2- methyl-1-Oxo-2-Butenyl) Quinoline (CHR5) was determined in Sprague-Dawley rats by using the oral gavage single-dose method. The LD50 was 2.73 g/kg for male rats and 2.22 g/kg for female rats. CHR5 produces a syndrome of general malaise and appears to target the upper gastrointestinal tract and the central nervous system. The predominate GFI sign was increased salivation. CNS signs included loss of equilibrium, twitching, tremors, hypotonia, and depression of the grasping, pinch, pull, and righting reflexes.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 01, 1986
- Accession Number
- ADA167754
Entities
People
- Carolyn M. Lewis
- Don W. Korte Jr.
- Earl W. Morgan
- Gerald F. S. Hiatt
Organizations
- Letterman Army Hospital